Appili Logo.png
Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks
March 12, 2024 07:12 ET | Appili Therapeutics Inc.
HALIFAX, Nova Scotia, March 12, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for...
Dyadic Logo Current.jpg
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
February 21, 2024 08:30 ET | Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...
Fairfield Market Research Logo (1).JPG
Global Biodefense Market Revenue Will Attain US$24.5 Bn by the End of 2030, Forecasts Fairfield Market Research in a New Report
April 27, 2023 12:56 ET | Fairfield Consultancy Services OPC Pvt Ltd
London, April 27, 2023 (GLOBE NEWSWIRE) -- Projected to demonstrate a healthy CAGR of 6.3% between 2023 and 2030, the global biodefense market valuation is expected to reach US$24.5 Bn by the end of...
Future Market Insights.png
Biodefense Market Sales are Estimated to Cross US$ 32.99 billion by 2033, Rise in Sales for Vaccines Surges the Demand for Biodefense | Future Market Insights, Inc.
February 15, 2023 19:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, Feb. 15, 2023 (GLOBE NEWSWIRE) -- It is estimated that the Biodefense Market is anticipated to reach US$ 32.99 billion by 2033 after being valued at US$ 16.31 billion in...
ARC logo.png
Biodefense Market Value Anticipated To Reach US$ 19.1 Billion By 2027: Acumen Research And Consulting
March 31, 2021 13:06 ET | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Biodefense Market– Global Industry Analysis, Market Size, Opportunities and...
CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) Published in Science Translational Medicine
January 07, 2021 06:00 ET | CytoDel Inc
Studies Show Cyto-111 Enables Delivery of Antibodies to Previously Inaccessible Intraneuronal Targets without the need for a Viral Vector or Transfection Supports the Development of New Approaches to...
Biodefense Market by
Biodefense Market by Type and Application - Global Industry Analysis and Forecast To 2022
November 21, 2017 06:49 ET | Crystal Market Research
LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- The latest trending report published by Crystal Market Research titled, Biodefense Market, approximates that the Biodefense Market size is estimated to...
PositiveID Corporati
PositiveID Corporation Announces 2015 Highlights and 2016 Outlook
January 11, 2016 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., Jan. 11, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today...
PositiveID Corporati
PositiveID Corporation to Present at the SeeThruEquity Microcap Healthcare Investor Conference on January 11, 2016
January 05, 2016 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., Jan. 05, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences tools and diagnostics company, announced today that its...
PositiveID Corporati
PositiveID Corporation Meets Major Development Milestone: New Firefly Dx Prototype With Real-Time Optics for Pathogen Detection
October 12, 2015 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., Oct. 12, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced...